Locally Delivered Minocycline in Advanced Periodontitis
Launched by MAHSA UNIVERSITY · Aug 29, 2019
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
The subjects for this randomized controlled, parallel arm study will be selected from the primary health care in the Faculty of Dentistry, MAHSA University. In this clinical trial, 50 patients with advanced periodontitis will be enrolled in the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • systematically healthy patients with age range between 20- 60 years,
- • diagnosed with untreated Advanced Periodontitis with a pocket depth ≥6mm around two or more teeth, in two or more quadrants.
- Exclusion Criteria:
- • Patients given antibiotics or anti-inflammatory drugs in the past 6 months,
- • allergic to tetracycline,
- • pregnant or nursing females,
- • those using chlorhexidine or any other mouth rinse
About Mahsa University
Mahsa University is a leading educational and research institution committed to advancing medical and health sciences through innovative clinical trials. With a focus on enhancing patient care and treatment outcomes, the university fosters collaboration among researchers, healthcare professionals, and industry partners. Its state-of-the-art facilities and interdisciplinary approach enable rigorous scientific inquiry, ensuring that clinical trials conducted under its auspices adhere to the highest ethical and regulatory standards. Mahsa University is dedicated to translating research findings into practical applications that benefit communities and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jenjarum, Selangor, Malaysia
Patients applied
Trial Officials
Tara Taiyeb Ali, MSc, FDSRCS
Principal Investigator
Mahsa University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials